Anzeige
Mehr »
Samstag, 28.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Edison Investment Research

ZeitAktuelle NachrichtenRatingLeser
02.06.OPAP - Sports and lottery success in Q125568While OPAP's Q125 results include some favourable one-offs, the highest-ever lottery jackpot and operator-friendly results in sports betting, there is a clear message of growing market share in non-exclusive...
► Artikel lesen
29.05.Global Fashion Group - Refined and redefined652Global Fashion Group (GFG) operates leading fashion and lifestyle platforms that enable brands to reach customers in a mix of developed and developing markets with high growth potential. Management...
► Artikel lesen
29.05.Immix Biopharma - Positive newsflow continues for NEXICART-2356Immix Biopharma has announced a positive clinical update for the US-based Phase I/II NEXICART-2 trial, investigating lead CAR-T candidate NXC-201 as a potential treatment for relapsed/refractory (r/r)...
► Artikel lesen
28.05.Rockwood Strategic - Different approach has favourable outcomes250Rockwood Strategic (RKW) is managed by Richard Staveley at Harwood Capital. He has a differentiated approach, aiming to generate a 15% annual internal rate of return (IRR) over a rolling five-year period...
► Artikel lesen
27.05.Cereno Scientific - Firing on all cylinders318In Q125, Cereno made tangible progress across both its clinical programmes. The period opened with new data for lead asset CS1 indicating disease-modifying signals, and was capped by FDA endorsement...
► Artikel lesen
27.05.Datatec - Strong performance drives increased dividend payout policy367Datatec reported a strong set of results for FY25, with gross profit, adjusted EBITDA and underlying EPS all ahead of our forecasts. All three divisions reported strong growth in adjusted EBITDA, highlighting...
► Artikel lesen
27.05.Alphamin Resources - Honing FY25 forecasts355Notwithstanding press headlines reading 'Alphamin Resources profit slumps in first quarter on DRC disruptions', the company's Q125 results were universally better than in Q124 and consistent with its...
► Artikel lesen
27.05.Alkane Resources - On the road to Mandalay371Since our last note on the company, Alkane Resources has announced its interim results, its Q325 quarterly activities report and, on 28 April, a merger of equals with Canada's Mandalay Resources Corporation....
► Artikel lesen
27.05.Kainos Group - Green shoots of growth301After a tough year, Kainos is seeing signs of improving demand, with Q425 revenue returning to growth. Workday Products continues to be the main growth driver and in Digital Services, the company should...
► Artikel lesen
27.05.Creo Medical - Rightsized and refocused253Creo Medical's FY24 results unveiled a streamlined business model focused on its core advanced energy platform, following the divestment of a 51% stake in its consumables arm, Creo Medical Europe (CME...
► Artikel lesen
23.05.The Platform Group - Strong momentum in Q125526The Platform Group's Q125 results show strong momentum with a seasonally high adjusted EBITDA margin. Coming so soon after the recent FY24 results, there is no change to management's guidance for the...
► Artikel lesen
23.05.Smiths News - New recycling MD underpins new activity potential323Smiths News' PBT increased by 11% in H125, a combination of higher profits and lower financing costs as both debt and debt margins declined. However, in addition to this and perhaps more exciting is...
► Artikel lesen
23.05.Games Workshop Group - Strong core in Q425604Games Workshop Group's year-end (2025) trading update shows a better Q4 than we expected, notably in its core business with high operational gearing. Licensing revenue and profit are broadly in line...
► Artikel lesen
23.05.BB Biotech - Optimistic about biotech's long-term prospects1.248During 2024 and early this year, the biotech sector began to show signs of a structural recovery, supported by positive clinical data, regulatory approvals, lower interest rates, commercial execution...
► Artikel lesen
22.05.OSE Immunotherapeutics - Strategic collaboration in mRNA technologies309OSE Immunotherapeutics has announced a new strategic collaboration with Inside Therapeutics and MiNT Laboratory (University of Angers) to develop mRNA therapies and accelerate nanodrug development....
► Artikel lesen
22.05.Herantis Pharma - Dedicated to disease modification for PD279Herantis is striving to develop disease-modifying treatments for central nervous system (CNS) conditions, with an initial focus on Parkinson's disease (PD). Lead asset HER-096 has a novel mechanism...
► Artikel lesen
21.05.Basilea Pharmaceutica - Zevtera hits the shelves in the US362Basilea Pharmaceutica has announced the launch of Zevtera, its lead anti-bacterial treatment, in the US by partner Innoviva Specialty Therapeutics (IST), marking a key strategic milestone for the company....
► Artikel lesen
21.05.ProCredit Holding - Investments starting to level off712ProCredit Holding (PCB) reported a Q125 annualised return on equity (ROE) of 9.5%, broadly in line with management's reiterated FY25 guidance of around 10% but down from 13.4% in Q124, as the company's...
► Artikel lesen
21.05.Carr's Group - Attractive options for cash or remain invested284Carr's Group's tender offer provides shareholders with the option to realise cash from the recent disposal of the Engineering division and/or remain invested in a refocused specialist agricultural group....
► Artikel lesen
21.05.Greggs - Better trading conditions, easing comparative321Greggs' AGM trading update indicates an improvement in revenue growth in recent months versus a relatively weak start to the year, as management notes better trading conditions, while the market context...
► Artikel lesen
21.05.4imprint Group - Holding steady against uncertain backdrop3554imprint's AGM statement outlines flat revenues year-on-year for the first four months, with order intake levels running around 2% down and stable average order values. We view this as a respectable...
► Artikel lesen
20.05.Canyon Resources - Additional funding from core shareholder255On 19 May, Canyon Resources announced that it has received an option exercise notice from its key shareholder Eagle Eye Asset Holdings (EEA). EEA will exercise 350m options, resulting in cash proceeds...
► Artikel lesen
20.05.Borussia Dortmund - Timed to perfection471Borussia Dortmund's strong Q325 results reflect a relatively busy football schedule with just under one-half of the cumulative home games of the season played in the period. It is safe to say the most...
► Artikel lesen
20.05.Topps Tiles - Back to revenue and profit growth311The key takeaways from Topps Tiles' (TPT's) H125 results are: 1) there is meaningful progress on the Mission 365 initiatives announced one year ago; 2) the company is back into revenue and profit growth...
► Artikel lesen
19.05.Deutsche Beteiligungs - Stay tuned for more in 2025744Deutsche Beteiligungs' (DBAG's) investment activity in Q125 was limited to one closed private equity (PE) investment (replacing external financing at an existing holding) and one private debt investment...
► Artikel lesen